Skip to main content

Mayo Clinic — Portfolio, Page 5

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

118
Companies
$2.1B
Total invested
$22.8M
Avg. check
45
Industries
Health Care 15Biotechnology 10Artificial Intelligence (AI) 8Software 6Medical 6Pharmaceutical 5+39 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 97–118 of 118
Bluesight
July 2023

Bluesight is a medication intelligence company that utilizes AI and machine learning to reduce risks and solve supply chain inefficiencies.

Artificial Intelligence (AI) · AlexandriaPrivate Equity
MEDIVIS
June 2023

Medivis is a medical technology company leveraging augmented reality and artificial intelligence to advance surgical care.

Artificial Intelligence (AI) · New York$20.0M Series A
Adaptive Phage Therapeutics
June 2023

Adaptive Phage Therapeutics provides therapeutic services intended to treat multi-drug resistant pathogenic bacteria.

Biotechnology · Bethesda$12.0M Series B
Lucem Health
May 2023

Lucem Health develops a remote diagnostics platform designed to connect remote patient telemetry and biosensing devices with AI algorithms.

Artificial Intelligence (AI) · Raleigh$7.7M Series A
R-Zero
February 2023

Smart building solutions that automates building and workforce efficiencies, to maximize the ROI of your real estate portfolio.

Energy Efficiency · San Francisco$105.0M Series C
nference
December 2022

nference is a software company that creates transformative technologies and products in healthcare.

Biotechnology · CambridgeNon Equity Assistance
Lisa Health
July 2022

Lisa Health creates advanced technology solutions for menopause and healthy aging.

Health Care · Oakland$2.5M Seed
Geneticure
June 2022

Geneticure is a personalized medicine company with patented tests that control chronic diseases faster than trial/error, with less cost

Biotechnology · Minneapolis$1.7M Seed
Ordr
June 2022

Ordr provides visibility and security for every connected device-- from traditional IT to newer and more vulnerable IoT, IoMT, and OT.

Artificial Intelligence (AI) · Santa Clara$40.0M Series C
HuidaGene Therapeutics
May 2022

HuidaGene is a global clinical-stage biotechnology company pioneering innovative gene therapies for neurology and ophthalmology.

Biopharma · ShanghaiSeries C
Theator
April 2022

Theator is a surgical intelligence platform that combines artificial intelligence and computer vision to improve surgeon performance.

Artificial Intelligence (AI) · Palo Alto$24.0M Series A
Tympany Medical
November 2021

Tympany Medical is an innovative MedTech Start Up based in Galway, Ireland.

Health Care · Galway$3.9M Seed
SimBioSys
October 2021

SimBioSys is developing a Computational Microscope to provide new insight into the behavior of cancers.

Biotechnology · Champaign$15.0M Series A
TripleBlind
October 2021

TripleBlind is a software company that provides scalable solution with simple API for privacy enhancing computation.

Big Data · Kansas City$24.0M Series A
Helix
June 2021

Helix is a population genomics company that is working to advance genomics research and integrate genomic data into clinical care.

Big Data · San Mateo$50.0M Series C
Atrian Medical
January 2021

Atrian Medical is an Irish medical device company.

Biotechnology · GalwayNon Equity Assistance
Caraway Therapeutics
November 2020

Rheostat Therapeutics is a bio therapeutics company.

Biotechnology · CambridgeGrant
GYANT
July 2020

GYANT is a digital front door solution for health systems that uses AI to navigate patients to the right care setting and resources.

Artificial Intelligence (AI) · San Francisco$13.6M Series A
Progentec Diagnostics
January 2020

Progentec is engaged in state of the art diagnostic interventions in therapeutic areas with a high level of unmet need.

Biotechnology · Oklahoma City$5.0M Series A
Sensely
October 2019

Sensely is a software developer and chatbot-based platform designed to assist insurance plan members and patients.

Artificial Intelligence (AI) · San Francisco$15.0M Series Unknown
Qrativ
July 2017

Qrativ is a developer of a drug purposing platform designed to reinvent the way treatments for diseases with unmet medical.

Artificial Intelligence (AI) · Cambridge$8.3M Series A
better.
April 2014

Better. is a personal health assistant app supported by The Mayo Clinic to help people live healthier lives.

Clinical Trials · Palo Alto$5.0M Seed

Where Mayo Clinic invests

Health Care15
Biotechnology10
Artificial Intelligence (AI)8
Software6
Medical6
Pharmaceutical5

About Mayo Clinic's portfolio

How many companies has Mayo Clinic invested in?▸

Mayo Clinic has invested in 118 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Mayo Clinic invest in?▸

Mayo Clinic's top investment sectors include Health Care, Biotechnology, Artificial Intelligence (AI), Software, Medical. The firm invests across 45 different industry categories.

What is Mayo Clinic's largest investment?▸

Among tracked funding rounds, R-Zero received $105.0M in a Series C round. Mayo Clinic's total known invested capital is $2.1B.

What is the average investment size for Mayo Clinic?▸

Mayo Clinic's average investment size is $22.8M across its portfolio of 118 companies.

What are Mayo Clinic's most recent investments?▸

Recent Mayo Clinic portfolio additions include Bluesight, MEDIVIS, Adaptive Phage Therapeutics, Lucem Health, R-Zero. These companies were founded in 2020 or later.

Reach the founders behind these 118 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →